Repligen Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
26.0%projected annual EPS growth
Analyst Coverage
20analysts covering
FY Revenue (est.)
$827Mnext fiscal year
FY EPS (est.)
$2.06next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 27 Oct 2026 |
| Q4 2026 Earnings Release | 23 Feb 2027 |
Monitoring Framework
Key Performance Indicators
Organic Revenue Growth Quarterly1,100.0%Target: 9%-13%
Process Analytics Franchise Growth Quarterly5,000.0%Target: >20%
Adjusted Gross Margin Quarterly5,550.0%Target: 53.6%-54.1%
Adjusted Operating Margin Quarterly1,540.0%Target: 15.1%-15.5%
Research as of 19 Jun 2026